Showing 3 of 3 recruiting trials for “cednik-syndrome”
Ascorbate in Myelodysplastic Syndrome
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
👨⚕️ Michael Wilkinson, MD, University of California, San Diego📍 1 site📅 Started Apr 2025View details ↗
A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases(C-MET Trial)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →